Herasight
2 known investors
HeraSight develops genetic tests for families, including preimplantation embryo screening that uses polygenic risk scores and carrier screening to predict risks for conditions such as Alzheimer's, schizophrenia, cancers, autism, and diabetes. It combines validated polygenic scoring with genetic counseling for prospective parents undergoing IVF.
Investors Β· 2
Frequently asked questions
- What does Herasight do?
- HeraSight develops genetic tests for families, including preimplantation embryo screening that uses polygenic risk scores and carrier screening to predict risks for conditions such as Alzheimer's, schizophrenia, cancers, autism, and diabetes. It combines validated polygenic scoring with genetic counseling for prospective parents undergoing IVF.
- Who are Herasight's investors?
- Herasight's investors include Draper Associates, NZVC.